Chakrabarti, B. http://orcid.org/0000-0002-0433-1785
Kane, B.
Barrow, C.
Stonebanks, J.
Reed, L.
Pearson, M. G.
Davies, L.
Osborne, M.
England, P.
Litchfield, D.
McKnight, E.
Angus, R. M. http://orcid.org/0000-0001-5987-5598
Funding for this research was provided by:
The STARRS-GM project has been developed as part of a Joint Working initiative between HInM (Health Innovation Manchester) and AstraZeneca UK.
Article History
Received: 5 September 2022
Accepted: 17 January 2023
First Online: 7 February 2023
Competing interests
: The CGC has been developed and owned by LungHealth Ltd. Drs. Chakrabarti, Angus, Davies, Professor Pearson and Mr. McKnight are all directors of LungHealth Ltd and were all involved in the development of the CGC. B.K., C.B., J.S., D.L., P.E., M.O., L.R. have no competing interests to declare. The STARRS-GM project has been developed as part of a Joint Working initiative between HInM (Health Innovation Manchester) and AstraZeneca UK. As part of this Joint Working Agreement, Astra Zeneca UK funded the licenses for the use of the LungHealth software, project management costs and the nurse resource to deliver clinics and to perform the initial audit and case-finding.